Targeting of AMPK/MTOR signaling in the management of atherosclerosis: Outmost leveraging
- 8 April 2025
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 309 (Pt 2) , 142933
Abstract
No abstract availableKeywords
Funding Information
- University of Bisha (UB-promising-34-1445)
This publication has 186 references indexed in Scilit:
- Glitazones and Glitazars2022
- Targeting the Microenvironment of Vulnerable Atherosclerotic Plaques: An Emerging Diagnosis and Therapy Strategy for AtherosclerosisAdvanced Materials, 2022
- Plaque‐Targeted Rapamycin Spherical Nucleic Acids for Synergistic Atherosclerosis TreatmentAdvanced Science, 2022
- mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapyEuropean Journal of Immunology, 2021
- The Effect of Curcumin in Improving Lipid Profile in Patients with Cardiovascular Risk Factors: A Systematic Review of Clinical Trials2021
- Autophagy, Hyperlipidemia, and Atherosclerosis2020
- Modulatory effects of curcumin on the atherogenic activities of inflammatory monocytes: Evidence from in vitro and animal models of human atherosclerosisBioFactors, 2019
- AMPK and Autophagy2019
- Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney FunctionJAMA, 2019
- Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathwaysHepatology, 2008